NCT05557825View on ClinicalTrials.gov

The Use of Photobiomodulation in the Management of Radiodermatitis in Head and Neck Cancer Patients

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

January 20, 2023

Primary Completion Date

August 1, 2023

Study Completion Date

August 1, 2023

Conditions
Radiodermatitis; AcuteRadiotherapy Side EffectHead and Neck Cancer
Interventions
RADIATION

Photobiomodulation Therapy

Focal low-level laser therapy, 1 to 3 Joules per point, depending on the degree of pain, wavelength 633 to 830 nm, transcutaneously on the surface of the tissue injured by radiotherapy, three times a week during radiotherapy treatment and two more applications after the end of radiotherapy

Trial Locations (1)

Unknown

Universidade Nove de Julho / Post-Graduate program Biophotonics Applied to Health Sciences, São Paulo

All Listed Sponsors
lead

University of Nove de Julho

OTHER